Benzinga | Nov 24, 2020 08:38AM EST

Ultragenyx To Present At Upcoming Healthcare Conferences On Dec. 1 And 2

NOVATO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, will present at the following upcoming investor conferences:



* Piper Sandler's 32nd Annual Healthcare Conference on Tuesday, December 1, 2020. The pre-recorded presentation is currently available on the company's website.

* Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 at 1:00 PM ET.

The live and archived webcast of the presentation will be accessible from the company's website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 90 days.